Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study.

Ruffieux, Yann; Fernandez Villalobos, Nathalie Veronica; Didden, Christiane; Haas, Andreas D; Chinogurei, Chido; Cornell, Morna; Egger, Matthias; Maartens, Gary; Folb, Naomi; Rohner, Eliane (2024). Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study. (In Press). Cancer epidemiology, biomarkers & prevention American Association for Cancer Research AACR 10.1158/1055-9965.EPI-24-0137

[img]
Preview
Text
epi-24-0137.pdf - Accepted Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

BACKGROUND

Several studies have found lower prostate cancer diagnosis rates among men with HIV (MWH) than men without HIV, but reasons for this finding remain unclear.

METHODS

We used claims data from a South African private medical insurance scheme (07/2017-07/2020) to assess prostate cancer diagnosis rates among men aged ≥18 years with and without HIV. Using flexible parametric survival models, we estimated hazard ratios (HR) for the association between HIV and incident prostate cancer diagnoses. We accounted for potential confounding by age, population group, and sexually transmitted infections (confounder-adjusted model), and additionally for potential mediation by prostatitis diagnoses, prostate-specific antigen (PSA) testing, and prostate biopsies (fully adjusted model).

RESULTS

We included 288 194 men, of whom 20 074 (7%) were living with HIV. Prostate cancer was diagnosed in 1 614 men without HIV (median age at diagnosis: 67 years) and in 82 MWH (median age at diagnosis: 60 years). In the unadjusted analysis, prostate cancer diagnosis rates were 35% lower among MWH than men without HIV (HR 0.65, 95% confidence interval [CI] 0.52-0-82). However, this association was no longer evident in the confounder-adjusted model (HR 1.03, 95% CI 0.82-1.30) or in the fully adjusted model (HR 1.14, 95% CI 0.91-1.44).

CONCLUSIONS

When accounting for potential confounders and mediators, our analysis found no evidence of lower prostate cancer diagnosis rates among men with HIV than men without HIV in South Africa.

IMPACT

Our results do not support the hypothesis that HIV decreases the risk of prostate cancer.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Ruffieux, Yann, Fernandez Villalobos, Nathalie Veronica, Didden, Christiane Helene, Haas, Andreas, Egger, Matthias, Rohner, Eliane

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1055-9965

Publisher:

American Association for Cancer Research AACR

Language:

English

Submitter:

Pubmed Import

Date Deposited:

08 May 2024 10:48

Last Modified:

09 May 2024 15:26

Publisher DOI:

10.1158/1055-9965.EPI-24-0137

PubMed ID:

38713162

BORIS DOI:

10.48350/196602

URI:

https://boris.unibe.ch/id/eprint/196602

Actions (login required)

Edit item Edit item
Provide Feedback